JAK3 and in situ carcinoma: To investigate whether the triplet combination overcomes GEM/CIS resistance under the physiological condition, we generated the GEM/CIS-resistant CCA animal models by subcutaneously implanting GEM/CIS-resistant CCA cells into severely immunocompromised BALB/CRag2-/-,Jak3-/- mice.